SEC 13F Intelligence

Taconic Capital Advisors LP / VRNA

Taconic Capital Advisors LP’s Verona Pharma PLC Position

Does Taconic Capital Advisors LP own Verona Pharma PLC (VRNA)? Not currently — the last reported position was 232.9K shares worth $25M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$25M
Q3 2025
Shares
232.9K
% of Portfolio
+5.16%
Quarters Held
1
position exited

Position History VRNA

Reported value by quarter
Q3 ’25: $25MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025232.9K$25M+5.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Taconic Capital Advisors LP’s full portfolio or all institutional holders of VRNA.